The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Anti-inflammatory Serums-Global Market Insights and Sales Trends 2024

Anti-inflammatory Serums-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1870912

No of Pages : 104

Synopsis
Anti-inflammatory Serums
The global Anti-inflammatory Serums market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Anti-inflammatory Serums in various end use industries. The expanding demands from the Online Retail and Offline Retail, are propelling Anti-inflammatory Serums market. CBD, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Blue Copper Peptide segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Anti-inflammatory Serums market, driven by demand from China, the second largest economy with some signs of stabilising, the Anti-inflammatory Serums market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti-inflammatory Serums, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti-inflammatory Serums market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti-inflammatory Serums market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti-inflammatory Serums sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti-inflammatory Serums covered in this report include The Ordinary, La Roche-Posay, SkinCeutical, Medik8, Dermalogica, Proya, Cosmedix, ULUKA and SAFERO, etc.
The global Anti-inflammatory Serums market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
The Ordinary
La Roche-Posay
SkinCeutical
Medik8
Dermalogica
Proya
Cosmedix
ULUKA
SAFERO
John Jeff
Biophyto-genesis
PURID
UNISKIN
Brandfree
Global Anti-inflammatory Serums market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti-inflammatory Serums market, Segment by Type:
CBD
Blue Copper Peptide
Resveratrol
Others
Global Anti-inflammatory Serums market, by Application
Online Retail
Offline Retail
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anti-inflammatory Serums manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anti-inflammatory Serums in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Anti-inflammatory Serums Market Overview
1.1 Anti-inflammatory Serums Product Overview
1.2 Anti-inflammatory Serums Market Segment by Type
1.2.1 CBD
1.2.2 Blue Copper Peptide
1.2.3 Resveratrol
1.2.4 Others
1.3 Global Anti-inflammatory Serums Market Size by Type
1.3.1 Global Anti-inflammatory Serums Market Size Overview by Type (2018-2029)
1.3.2 Global Anti-inflammatory Serums Historic Market Size Review by Type (2018-2023)
1.3.3 Global Anti-inflammatory Serums Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti-inflammatory Serums Sales Breakdown by Type (2018-2023)
1.4.2 Europe Anti-inflammatory Serums Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Anti-inflammatory Serums Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Anti-inflammatory Serums Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Anti-inflammatory Serums Sales Breakdown by Type (2018-2023)
2 Global Anti-inflammatory Serums Market Competition by Company
2.1 Global Top Players by Anti-inflammatory Serums Sales (2018-2023)
2.2 Global Top Players by Anti-inflammatory Serums Revenue (2018-2023)
2.3 Global Top Players by Anti-inflammatory Serums Price (2018-2023)
2.4 Global Top Manufacturers Anti-inflammatory Serums Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti-inflammatory Serums Market Competitive Situation and Trends
2.5.1 Anti-inflammatory Serums Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti-inflammatory Serums Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti-inflammatory Serums as of 2022)
2.7 Date of Key Manufacturers Enter into Anti-inflammatory Serums Market
2.8 Key Manufacturers Anti-inflammatory Serums Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti-inflammatory Serums Status and Outlook by Region
3.1 Global Anti-inflammatory Serums Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Anti-inflammatory Serums Historic Market Size by Region
3.2.1 Global Anti-inflammatory Serums Sales in Volume by Region (2018-2023)
3.2.2 Global Anti-inflammatory Serums Sales in Value by Region (2018-2023)
3.2.3 Global Anti-inflammatory Serums Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Anti-inflammatory Serums Forecasted Market Size by Region
3.3.1 Global Anti-inflammatory Serums Sales in Volume by Region (2024-2029)
3.3.2 Global Anti-inflammatory Serums Sales in Value by Region (2024-2029)
3.3.3 Global Anti-inflammatory Serums Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Anti-inflammatory Serums by Application
4.1 Anti-inflammatory Serums Market Segment by Application
4.1.1 Online Retail
4.1.2 Offline Retail
4.2 Global Anti-inflammatory Serums Market Size by Application
4.2.1 Global Anti-inflammatory Serums Market Size Overview by Application (2018-2029)
4.2.2 Global Anti-inflammatory Serums Historic Market Size Review by Application (2018-2023)
4.2.3 Global Anti-inflammatory Serums Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti-inflammatory Serums Sales Breakdown by Application (2018-2023)
4.3.2 Europe Anti-inflammatory Serums Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Anti-inflammatory Serums Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Anti-inflammatory Serums Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Anti-inflammatory Serums Sales Breakdown by Application (2018-2023)
5 North America Anti-inflammatory Serums by Country
5.1 North America Anti-inflammatory Serums Historic Market Size by Country
5.1.1 North America Anti-inflammatory Serums Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Anti-inflammatory Serums Sales in Volume by Country (2018-2023)
5.1.3 North America Anti-inflammatory Serums Sales in Value by Country (2018-2023)
5.2 North America Anti-inflammatory Serums Forecasted Market Size by Country
5.2.1 North America Anti-inflammatory Serums Sales in Volume by Country (2024-2029)
5.2.2 North America Anti-inflammatory Serums Sales in Value by Country (2024-2029)
6 Europe Anti-inflammatory Serums by Country
6.1 Europe Anti-inflammatory Serums Historic Market Size by Country
6.1.1 Europe Anti-inflammatory Serums Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Anti-inflammatory Serums Sales in Volume by Country (2018-2023)
6.1.3 Europe Anti-inflammatory Serums Sales in Value by Country (2018-2023)
6.2 Europe Anti-inflammatory Serums Forecasted Market Size by Country
6.2.1 Europe Anti-inflammatory Serums Sales in Volume by Country (2024-2029)
6.2.2 Europe Anti-inflammatory Serums Sales in Value by Country (2024-2029)
7 Asia-Pacific Anti-inflammatory Serums by Region
7.1 Asia-Pacific Anti-inflammatory Serums Historic Market Size by Region
7.1.1 Asia-Pacific Anti-inflammatory Serums Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Anti-inflammatory Serums Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Anti-inflammatory Serums Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Anti-inflammatory Serums Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti-inflammatory Serums Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Anti-inflammatory Serums Sales in Value by Region (2024-2029)
8 Latin America Anti-inflammatory Serums by Country
8.1 Latin America Anti-inflammatory Serums Historic Market Size by Country
8.1.1 Latin America Anti-inflammatory Serums Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Anti-inflammatory Serums Sales in Volume by Country (2018-2023)
8.1.3 Latin America Anti-inflammatory Serums Sales in Value by Country (2018-2023)
8.2 Latin America Anti-inflammatory Serums Forecasted Market Size by Country
8.2.1 Latin America Anti-inflammatory Serums Sales in Volume by Country (2024-2029)
8.2.2 Latin America Anti-inflammatory Serums Sales in Value by Country (2024-2029)
9 Middle East and Africa Anti-inflammatory Serums by Country
9.1 Middle East and Africa Anti-inflammatory Serums Historic Market Size by Country
9.1.1 Middle East and Africa Anti-inflammatory Serums Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Anti-inflammatory Serums Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Anti-inflammatory Serums Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Anti-inflammatory Serums Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti-inflammatory Serums Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Anti-inflammatory Serums Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 The Ordinary
10.1.1 The Ordinary Company Information
10.1.2 The Ordinary Introduction and Business Overview
10.1.3 The Ordinary Anti-inflammatory Serums Sales, Revenue and Gross Margin (2018-2023)
10.1.4 The Ordinary Anti-inflammatory Serums Products Offered
10.1.5 The Ordinary Recent Development
10.2 La Roche-Posay
10.2.1 La Roche-Posay Company Information
10.2.2 La Roche-Posay Introduction and Business Overview
10.2.3 La Roche-Posay Anti-inflammatory Serums Sales, Revenue and Gross Margin (2018-2023)
10.2.4 La Roche-Posay Anti-inflammatory Serums Products Offered
10.2.5 La Roche-Posay Recent Development
10.3 SkinCeutical
10.3.1 SkinCeutical Company Information
10.3.2 SkinCeutical Introduction and Business Overview
10.3.3 SkinCeutical Anti-inflammatory Serums Sales, Revenue and Gross Margin (2018-2023)
10.3.4 SkinCeutical Anti-inflammatory Serums Products Offered
10.3.5 SkinCeutical Recent Development
10.4 Medik8
10.4.1 Medik8 Company Information
10.4.2 Medik8 Introduction and Business Overview
10.4.3 Medik8 Anti-inflammatory Serums Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Medik8 Anti-inflammatory Serums Products Offered
10.4.5 Medik8 Recent Development
10.5 Dermalogica
10.5.1 Dermalogica Company Information
10.5.2 Dermalogica Introduction and Business Overview
10.5.3 Dermalogica Anti-inflammatory Serums Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Dermalogica Anti-inflammatory Serums Products Offered
10.5.5 Dermalogica Recent Development
10.6 Proya
10.6.1 Proya Company Information
10.6.2 Proya Introduction and Business Overview
10.6.3 Proya Anti-inflammatory Serums Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Proya Anti-inflammatory Serums Products Offered
10.6.5 Proya Recent Development
10.7 Cosmedix
10.7.1 Cosmedix Company Information
10.7.2 Cosmedix Introduction and Business Overview
10.7.3 Cosmedix Anti-inflammatory Serums Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Cosmedix Anti-inflammatory Serums Products Offered
10.7.5 Cosmedix Recent Development
10.8 ULUKA
10.8.1 ULUKA Company Information
10.8.2 ULUKA Introduction and Business Overview
10.8.3 ULUKA Anti-inflammatory Serums Sales, Revenue and Gross Margin (2018-2023)
10.8.4 ULUKA Anti-inflammatory Serums Products Offered
10.8.5 ULUKA Recent Development
10.9 SAFERO
10.9.1 SAFERO Company Information
10.9.2 SAFERO Introduction and Business Overview
10.9.3 SAFERO Anti-inflammatory Serums Sales, Revenue and Gross Margin (2018-2023)
10.9.4 SAFERO Anti-inflammatory Serums Products Offered
10.9.5 SAFERO Recent Development
10.10 John Jeff
10.10.1 John Jeff Company Information
10.10.2 John Jeff Introduction and Business Overview
10.10.3 John Jeff Anti-inflammatory Serums Sales, Revenue and Gross Margin (2018-2023)
10.10.4 John Jeff Anti-inflammatory Serums Products Offered
10.10.5 John Jeff Recent Development
10.11 Biophyto-genesis
10.11.1 Biophyto-genesis Company Information
10.11.2 Biophyto-genesis Introduction and Business Overview
10.11.3 Biophyto-genesis Anti-inflammatory Serums Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Biophyto-genesis Anti-inflammatory Serums Products Offered
10.11.5 Biophyto-genesis Recent Development
10.12 PURID
10.12.1 PURID Company Information
10.12.2 PURID Introduction and Business Overview
10.12.3 PURID Anti-inflammatory Serums Sales, Revenue and Gross Margin (2018-2023)
10.12.4 PURID Anti-inflammatory Serums Products Offered
10.12.5 PURID Recent Development
10.13 UNISKIN
10.13.1 UNISKIN Company Information
10.13.2 UNISKIN Introduction and Business Overview
10.13.3 UNISKIN Anti-inflammatory Serums Sales, Revenue and Gross Margin (2018-2023)
10.13.4 UNISKIN Anti-inflammatory Serums Products Offered
10.13.5 UNISKIN Recent Development
10.14 Brandfree
10.14.1 Brandfree Company Information
10.14.2 Brandfree Introduction and Business Overview
10.14.3 Brandfree Anti-inflammatory Serums Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Brandfree Anti-inflammatory Serums Products Offered
10.14.5 Brandfree Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti-inflammatory Serums Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti-inflammatory Serums Industrial Chain Analysis
11.4 Anti-inflammatory Serums Market Dynamics
11.4.1 Anti-inflammatory Serums Industry Trends
11.4.2 Anti-inflammatory Serums Market Drivers
11.4.3 Anti-inflammatory Serums Market Challenges
11.4.4 Anti-inflammatory Serums Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti-inflammatory Serums Distributors
12.3 Anti-inflammatory Serums Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’